SCHEMBL7834299

SCHEMBL7834299

CNc1nc(-c2ccccc2)ccc1N

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2K3 P46734 1/20 0.49
TDP1 Q9NUW8 2/20 0.47
ASIC3 Q9UHC3 1/20 0.46
ALDH1A1 P00352 4/20 0.45
KDM4E B2RXH2 3/20 0.45
GAA P10253 2/20 0.45
GLA P06280 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
MEN1 O00255 1/20 0.43
RAB9A P51151 1/20 0.43
KMT2A Q03164 1/20 0.43
NLRP3 Q96P20 1/20 0.43
ADORA2A P29274 3/20 0.43
AURKA O14965 1/20 0.43
HSP90AA1 P07900 1/20 0.43
PRKACA P17612 1/20 0.43
ADORA1 P30542 2/20 0.42
HPGD P15428 1/20 0.42
ACHE P22303 1/20 0.41
XDH P47989 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11237884 0.84 HDAC2 (0.52) MAP2K3ALDH1A1KDM4ERAB9AHPGD
SCHEMBL3652404 0.82 CYP1A2 (0.50) ALDH1A1KDM4EMEN1RAB9AKMT2A
SCHEMBL12172514 0.80 MKNK2 (0.53) MAP2K3ASIC3ALDH1A1KDM4EGAA
SCHEMBL6618672 0.75 ALDH1A1 (0.55) MAP2K3ASIC3ALDH1A1KDM4EGAA
SCHEMBL4053052 0.74 MAP2K3 (0.56) MAP2K3ASIC3ALDH1A1KDM4EMEN1
SCHEMBL5336795 0.74 KDM4E (0.52) TDP1ALDH1A1KDM4EGAAGLA
SCHEMBL3642934 0.74 ADORA3 (0.59) MAP2K3ADORA1
SCHEMBL22050094 0.74 MAPT (0.46) AURKAMAPTCLK4
SCHEMBL16285494 0.73 TDP1 (0.46) TDP1ALDH1A1KDM4EGAAGLA
SCHEMBL27340756 0.73 KDM4E (0.50) TDP1ALDH1A1KDM4EGAAGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0676398-B1 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO CO (JP) 2001-10-24 EP disclosed
CN-1060173-C Heterocyclic compound with activity against diabetes and preparation and application of same MITSUTAKA CO LTD (JP) 2001-01-03 CN disclosed
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 US disclosed
EP-1022274-A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use Sankyo Company Limited (JP) 2000-07-26 EP disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 US disclosed
US-5962470-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 1999-10-05 US disclosed
US-5834501-A TREATING DIABETES OR HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1998-11-10 US disclosed
US-5739345-A HYPOGLYCEMIC AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1998-04-14 US disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 US disclosed
CN-1118781-A Heterocyclic compound with activity against diabetes and preparation and application of same MITSUTAKA CO LTD (JP) 1996-03-20 CN disclosed
EP-0676398-A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO COMPANY LIMITED (JP) 1995-10-11 EP disclosed